Café

© 2026 Longbridge｜Terms of Service Privacy Policy

PEGBIO CO-B

02565

6.2905.54% ( +0.330 )

Delay Closed: Aug 25, 16:08:14

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Nine Dragons Raises Forecast by 77% as Hong Kong Niche Sectors See Divergent Fund Flows
Global Report·5 hours ago
01770-19.37%02565+5.54%
Hong Kong Mid-Caps Navigate Q3 Earnings: Biotech Milestones and Crypto Tailwinds
Global Report·7 hours ago
02565+5.54%01611-0.94%
PegBio FY26 H1 net loss more than doubles to RMB 216.2 million
PUBT·8 hours ago
02565+5.54%
Rani Therapeutics Expands Oral Biologics Push With Obesity, Immunology Pipeline
Market Beat·Aug 16 at 03:01 PM
RANI-2.01%CHGCY+0.05%
Lexaria Bioscience Stock Rallies Thursday: What Investors Need to Know
benzinga_article·Aug 13 at 02:18 PM
LEXX+6.07%02565+5.54%
Lexaria signs material transfer agreement with PegBio to test DehydraTECH with GLP-1 molecule
PUBT·Aug 13 at 08:00 AM
LEXX+6.07%02565+5.54%
PegBio schedules board meeting to review interim results
PUBT·Aug 13 at 03:58 AM
02565+5.54%
PegaBio surges nearly 9% in Hong Kong trading on GLP-1 drug milestone
HK Stock Market Update·Aug 12 at 10:12 PM
02565+5.54%
Paige BioMedical rises 1.1% in Hong Kong after intraday surge
HK Stock Market Update·Aug 11 at 08:52 PM
02565+5.54%
PegBio gains 2% in Hong Kong trading as Pidacang prescriptions roll out
HK Stock Market Update·Aug 9 at 08:45 PM
02565+5.54%
Paige Bio-B climbs 4% in Hong Kong trading
HK Stock Market Update·Aug 9 at 08:44 PM
02565+5.54%
PegBio surges 23% in Hong Kong as GLP-1 drug enters clinical use
HK Stock Market Update·Aug 7 at 03:06 AM
02565+5.54%
Paige Bio-medicine-B soars 25% after intraday plunge on GLP-1 drug
HK Stock Market Update·Aug 7 at 02:57 AM
02565+5.54%
The Restructuring of Hong Kong's Value Chain: From Channel Aggregators to IP Creators
Global Report·Aug 5 at 04:13 AM
02105-3.30%09636+0.67%